ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 752879 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 752879; 2) Community: the network communities that were significantly associated with the response to NSC 752879; 3) Molecule: the relationships between components within communities and NSC 752879; 4) MDR: the compounds that were significantly associated with the NSC 752879.

NSC Compound Enrichment Correlation
NSC 719412 Null 0.038689522570041 0.23158275
NSC 726262 1,1'-{[(bispropane-1,N-diyl)piperzine]dioxy}bis[(11aS)-7-met hoxy-1,2,3,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepi n-5-one 0.038689522570041 -0.28736532
NSC 728220 1-(3-Bromo-phenyl)-3-(pyridin-2-ylsulfanyl)-propenone 0.038689522570041 -0.20126873
NSC 737613 Null 0.038689522570041 -0.33370672
NSC 740385 7-fluoro-2-benzoyl-3-trifluoromethylquioxaline 1,4-dioxide 0.038689522570041 -0.35397426
NSC 740602 Null 0.038689522570041 -0.29124224
NSC 756251 GW559768X 0.0386895225700413 0.4342263
NSC 763646 (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole 0.0386895225700413 -0.40495645
NSC 94600 Camptothecin 0.0386895225700413 -0.053122004
NSC 283440 B633439K049 0.0401206532535668 -0.11941608
Total:62  Current:51    [First] [Prev] [Next] [Last]